المؤلفون: Julg B; Ragon Institute of Mass General, MIT and Harvard, Cambridge, MA, USA. bjulg@mgh.harvard.edu.; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA. bjulg@mgh.harvard.edu., Walker-Sperling VEK; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Wagh K; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, USA.; New Mexico Consortium, Los Alamos, NM, USA., Aid M; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Stephenson KE; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Zash R; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Liu J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Nkolola JP; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Hoyt A; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Castro M; Vaccine Research Center, National Institute of Health, Bethesda, MD, USA., Serebryannyy L; Vaccine Research Center, National Institute of Health, Bethesda, MD, USA., Yanosick K; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Speidel T; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Borducchi EN; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Murzda T; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Maxfield L; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Arduino R; Houston AIDS Research Team, McGovern Medical School at The University of Texas Health Science Center, Houston, TX, USA., McDermott AB; Vaccine Research Center, National Institute of Health, Bethesda, MD, USA., Gama L; Vaccine Research Center, National Institute of Health, Bethesda, MD, USA., Giorgi EE; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, USA.; New Mexico Consortium, Los Alamos, NM, USA., Koup RA; Vaccine Research Center, National Institute of Health, Bethesda, MD, USA., Seaman MS; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Rolle CP; Orlando Immunology Center, Orlando, FL, USA., DeJesus E; Orlando Immunology Center, Orlando, FL, USA., Li W; University of Massachusetts, Lowell, MA, USA., Korber B; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, USA.; New Mexico Consortium, Los Alamos, NM, USA., Barouch DH; Ragon Institute of Mass General, MIT and Harvard, Cambridge, MA, USA. dbarouch@bidmc.harvard.edu.; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA. dbarouch@bidmc.harvard.edu.

المصدر: Nature medicine [Nat Med] 2024 Sep 12. Date of Electronic Publication: 2024 Sep 12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

المؤلفون: Mathai R; University of Central Florida, College of Medicine, Orlando, USA., Hinestrosa F; Orlando Immunology Center, Orlando, FL, USA., DeJesus E; University of Central Florida, College of Medicine, Orlando, USA.; Orlando Immunology Center, Orlando, FL, USA., Rolle CP; Orlando Immunology Center, Orlando, FL, USA.; Emory University Rollins School of Public Health, Atlanta, GA, USA.

المصدر: Journal of investigative medicine : the official publication of the American Federation for Clinical Research [J Investig Med] 2023 Dec; Vol. 71 (8), pp. 946-952. Date of Electronic Publication: 2023 Jun 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 9501229 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1708-8267 (Electronic) Linking ISSN: 10815589 NLM ISO Abbreviation: J Investig Med Subsets: MEDLINE

مواضيع طبية MeSH: Healthcare Disparities* , HIV Infections*/therapy , Sexual Health*, Humans ; Black or African American ; HIV ; Retrospective Studies ; White ; Hispanic or Latino

المؤلفون: Rolle CP; Orlando Immunology Center, Orlando, Florida, USA., Berhe M; Baylor University Medical Center, Dallas, Texas, USA., Singh T; DAP Health, Palm Springs, California, USA., Ortiz R; Bliss Healthcare Services, Orlando, Florida, USA., Wurapa A; Infectious Disease Specialists of Atlanta, Decatur, Georgia, USA., Ramgopal M; Midway Immunology and Research Center, Fort Pierce, Florida, USA., Jayaweera DT; Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida, USA., Leone PA; ViiV Healthcare, Durham, North Carolina, USA., Matthews JE; ViiV Healthcare, Durham, North Carolina, USA., Cupo M; GSK, Upper Providence, Pennsylvania, USA., Underwood MR; ViiV Healthcare, Durham, North Carolina, USA., Angelis K; GSK, Brentford, United Kingdom., Wynne BR; ViiV Healthcare, Durham, North Carolina, USA., Merrill D; ViiV Healthcare, Durham, North Carolina, USA., Nguyen C; ViiV Healthcare, Durham, North Carolina, USA., van Wyk J; ViiV Healthcare, Brentford, United Kingdom., Zolopa AR; ViiV Healthcare, Durham, North Carolina, USA.; Stanford University, Palo Alto, California, USA.

المصدر: Open forum infectious diseases [Open Forum Infect Dis] 2023 Mar 01; Vol. 10 (3), pp. ofad101. Date of Electronic Publication: 2023 Mar 01 (Print Publication: 2023).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Published by Oxford University Press on behalf of the Infectious Diseases Society of America Country of Publication: United States NLM ID: 101637045 Publication Model: eCollection Cited Medium: Print ISSN: 2328-8957 (Print) Linking ISSN: 23288957 NLM ISO Abbreviation: Open Forum Infect Dis Subsets: PubMed not MEDLINE

المؤلفون: Rolle CP; Orlando Immunology Center, Orlando, FL, USA.; Department of Global Health, Emory University Rollins School of Public Health, Atlanta, GA, USA., Castano J; Orlando Immunology Center, Orlando, FL, USA., Nguyen V; Orlando Immunology Center, Orlando, FL, USA., Patel K; 2158Gilead Sciences, Foster City, CA, USA., Hinestrosa F; Orlando Immunology Center, Orlando, FL, USA.; 124506University of Central Florida College of Medicine, Orlando, FL, USA., DeJesus E; Orlando Immunology Center, Orlando, FL, USA.; 124506University of Central Florida College of Medicine, Orlando, FL, USA.

المصدر: Antiviral therapy [Antivir Ther] 2023 Feb; Vol. 28 (2), pp. 13596535231163703.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 9815705 Publication Model: Print Cited Medium: Internet ISSN: 2040-2058 (Electronic) Linking ISSN: 13596535 NLM ISO Abbreviation: Antivir Ther Subsets: MEDLINE

مواضيع طبية MeSH: HIV Infections*/drug therapy , HIV Infections*/diagnosis , Anti-HIV Agents*/adverse effects , HIV Integrase Inhibitors*/adverse effects, Humans ; Raltegravir Potassium/adverse effects ; Integrase Inhibitors/therapeutic use ; Heterocyclic Compounds, 3-Ring/adverse effects ; Pyridones/adverse effects ; Emtricitabine/therapeutic use ; Cobicistat/adverse effects

المؤلفون: Maaske J; Clinical Development, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States., Sproule S; Biometrics, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States., Falsey AR; University of Rochester School of Medicine and Dentistry, Rochester, NY, United States.; Rochester Regional Health, Rochester, NY, United States., Sobieszczyk ME; Division of Infectious Diseases, Department of Medicine, Vagelos College of Physicians and Surgeons, New York-Presbyterian Columbia University Irving Medical Center, New York, NY, United States., Luetkemeyer AF; Zuckerberg San Francisco General, University of California, San Francisco, San Francisco, CA, United States., Paulsen GC; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, United States.; Division of Pediatric Infectious Diseases, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, United States., Riddler SA; Division of Infectious Diseases, Department of Medicine, University of Pittsburgh, Pittsburgh, PA, United States., Robb ML; Walter Reed Army Institute of Research, Silver Spring, MD, United States., Rolle CP; Orlando Immunology Center, Orlando, FL, United States., Sha BE; Division of Infectious Diseases, Department of Internal Medicine, Rush University Medical Center, Chicago, IL, United States., Tong T; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States., Ahani B; Bioinformatics, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States., Aksyuk AA; Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States., Bansal H; Biometrics, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States., Egan T; Biometrics, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States., Jepson B; Biometrics, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States., Padilla M; Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States., Patel N; Biometrics, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States., Shoemaker K; Biometrics, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States., Stanley AM; Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States., Swanson PA; Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States., Wilkins D; Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States., Villafana T; Clinical Development, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States., Green JA; Clinical Development, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Cambridge, United Kingdom., Kelly EJ; Translational Medicine, Vaccines & Immune Therapies, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, United States.

المصدر: Frontiers in immunology [Front Immunol] 2023 Jan 13; Vol. 13, pp. 1062067. Date of Electronic Publication: 2023 Jan 13 (Print Publication: 2022).

نوع المنشور: Clinical Trial, Phase III; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.

بيانات الدورية: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE

مواضيع طبية MeSH: ChAdOx1 nCoV-19*/immunology , COVID-19*/immunology , COVID-19*/prevention & control, Humans ; CD8-Positive T-Lymphocytes ; Pandemics ; SARS-CoV-2 ; Immunity, Humoral ; Immunity, Cellular

SCR Disease Name: COVID-19 breakthrough infections

المؤلفون: Julg B; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Stephenson KE; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Wagh K; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, USA.; New Mexico Consortium, Los Alamos, NM, USA., Tan SC; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Zash R; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Walsh S; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Ansel J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Kanjilal D; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Nkolola J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Walker-Sperling VEK; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Ophel J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Yanosick K; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Borducchi EN; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Maxfield L; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Abbink P; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Peter L; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Yates NL; Duke Human Vaccine Institute, Duke University, Durham, NC, USA., Wesley MS; Duke Human Vaccine Institute, Duke University, Durham, NC, USA., Hassell T; International AIDS Vaccine Initiative, New York, NY, USA., Gelderblom HC; International AIDS Vaccine Initiative, New York, NY, USA.; Icosavax Inc., Seattle, WA, USA., deCamp A; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Mayer BT; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Sato A; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Gerber MW; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Giorgi EE; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, USA.; New Mexico Consortium, Los Alamos, NM, USA., Gama L; Vaccine Research Center, National Institute of Health, Bethesda, MD, USA., Koup RA; Vaccine Research Center, National Institute of Health, Bethesda, MD, USA., Mascola JR; Vaccine Research Center, National Institute of Health, Bethesda, MD, USA., Monczor A; Houston AIDS Research Team, McGovern Medical School at The University of Texas Health Science Center at Houston, Houston, TX, USA., Lupo S; Houston AIDS Research Team, McGovern Medical School at The University of Texas Health Science Center at Houston, Houston, TX, USA., Rolle CP; Orlando Immunology Center, Orlando, FL, USA., Arduino R; Houston AIDS Research Team, McGovern Medical School at The University of Texas Health Science Center at Houston, Houston, TX, USA., DeJesus E; Orlando Immunology Center, Orlando, FL, USA., Tomaras GD; Duke Human Vaccine Institute, Duke University, Durham, NC, USA., Seaman MS; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Korber B; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, USA.; New Mexico Consortium, Los Alamos, NM, USA., Barouch DH; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA. dbarouch@bidmc.harvard.edu.; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA. dbarouch@bidmc.harvard.edu.

المصدر: Nature medicine [Nat Med] 2022 Jun; Vol. 28 (6), pp. 1288-1296. Date of Electronic Publication: 2022 May 12.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

مواضيع طبية MeSH: HIV Infections* , HIV Seropositivity* , HIV-1*, Adult ; Antibodies, Monoclonal/adverse effects ; Antibodies, Neutralizing ; Antiviral Agents/therapeutic use ; Broadly Neutralizing Antibodies ; HIV Antibodies ; Humans ; Viremia/drug therapy

المؤلفون: Rolle CP; Orlando Immunology Center, Orlando, FL., Berhe M; Baylor University Medical Center, Dallas, TX., Singh T; Desert AIDS Project, Palm Springs, CA., Ortiz R; Bliss Healthcare Services, Orlando, FL., Wurapa A; Infectious Disease Specialists of Atlanta, Decatur, GA., Ramgopal M; Midway Immunology and Research Center, Fort Pierce, FL., Leone PA; Medical Department., Matthews JE; Clinical Development., Dalessandro M; Clinical Development., Underwood MR; Clinical Virology, Translational Medical Research, ViiV Healthcare, Research Triangle Park, NC, USA., Angelis K; Department of Biostatistics, GlaxoSmithKline, Brentford, UK., Wynne BR; Medicines Development., Merrill D; Research Department., Nguyen C; Regional Medical Department, ViiV Healthcare, Research Triangle Park, NC, USA., van Wyk J; Global Medical Department, ViiV Healthcare, Brentford, UK., Zolopa AR; Department of Medical Affairs, ViiV Healthcare, Research Triangle Park, NC.; Stanford University, Palo Alto, CA, USA.

المصدر: AIDS (London, England) [AIDS] 2021 Oct 01; Vol. 35 (12), pp. 1957-1965.

نوع المنشور: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Video-Audio Media

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 8710219 Publication Model: Print Cited Medium: Internet ISSN: 1473-5571 (Electronic) Linking ISSN: 02699370 NLM ISO Abbreviation: AIDS Subsets: MEDLINE

مواضيع طبية MeSH: Anti-HIV Agents*/adverse effects , HIV Infections*/complications , HIV Infections*/drug therapy , HIV-1*, Adult ; Female ; Heterocyclic Compounds, 3-Ring/adverse effects ; Humans ; Lamivudine/adverse effects ; Male ; Oxazines/therapeutic use ; Piperazines/therapeutic use ; Pyridones

المؤلفون: Stephenson KE; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA., Julg B; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA.; Infectious Disease Division, Massachusetts General Hospital, Boston, MA, USA., Tan CS; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA, USA., Zash R; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA.; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA, USA., Walsh SR; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Rolle CP; Orlando Immunology Center, Orlando, FL, USA., Monczor AN; McGovern Medical School at The University of Texas Health Science Center, Houston, TX, USA., Lupo S; McGovern Medical School at The University of Texas Health Science Center, Houston, TX, USA., Gelderblom HC; International AIDS Vaccine Initiative, New York, NY, USA., Ansel JL; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Kanjilal DG; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Maxfield LF; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Nkolola J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Borducchi EN; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Abbink P; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Liu J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Peter L; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Chandrashekar A; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Nityanandam R; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Lin Z; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Setaro A; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Sapiente J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Chen Z; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA., Sunner L; International AIDS Vaccine Initiative, New York, NY, USA., Cassidy T; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, USA., Bennett C; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Sato A; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Mayer B; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Perelson AS; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, USA., deCamp A; Statistical Center for HIV/AIDS Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, WA, USA., Priddy FH; International AIDS Vaccine Initiative, New York, NY, USA., Wagh K; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, USA., Giorgi EE; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, USA., Yates NL; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.; Departments of Surgery, Immunology and Molecular Genetics and Microbiology, Duke University, Durham, NC, USA., Arduino RC; McGovern Medical School at The University of Texas Health Science Center, Houston, TX, USA., DeJesus E; Orlando Immunology Center, Orlando, FL, USA., Tomaras GD; Duke Human Vaccine Institute, Duke University, Durham, NC, USA.; Departments of Surgery, Immunology and Molecular Genetics and Microbiology, Duke University, Durham, NC, USA., Seaman MS; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA., Korber B; Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, NM, USA.; New Mexico Consortium, Los Alamos, NM, USA., Barouch DH; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA, USA. dbarouch@bidmc.harvard.edu.; Division of Infectious Diseases, Beth Israel Deaconess Medical Center, Boston, MA, USA. dbarouch@bidmc.harvard.edu.; Ragon Institute of MGH, MIT and Harvard, Cambridge, MA, USA. dbarouch@bidmc.harvard.edu.

المصدر: Nature medicine [Nat Med] 2021 Oct; Vol. 27 (10), pp. 1718-1724. Date of Electronic Publication: 2021 Oct 07.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE

مواضيع طبية MeSH: Antiviral Agents/*administration & dosage , Broadly Neutralizing Antibodies/*administration & dosage , HIV Infections/*drug therapy , HIV-1/*drug effects, Adult ; Antiretroviral Therapy, Highly Active ; Antiviral Agents/immunology ; Antiviral Agents/pharmacokinetics ; Broadly Neutralizing Antibodies/immunology ; CD4-Positive T-Lymphocytes/drug effects ; CD4-Positive T-Lymphocytes/virology ; Double-Blind Method ; Female ; HIV Envelope Protein gp120/antagonists & inhibitors ; HIV Envelope Protein gp120/immunology ; HIV Infections/genetics ; HIV Infections/pathology ; HIV Infections/virology ; HIV-1/pathogenicity ; Humans ; Male ; Middle Aged ; Peptide Fragments/antagonists & inhibitors ; Peptide Fragments/immunology ; Placebos ; Viral Load/drug effects ; Viral Load/immunology ; Young Adult

المؤلفون: Rolle CP; Orlando Immunology Center, Orlando, FL.; Department of Global Health, Emory University Rollins School of Public Health, Atlanta, GA., Nguyen V; University of Central Florida College of Medicine, Orlando, FL., Patel K; Gilead Sciences, Foster City, CA., Cruz D; Orlando Immunology Center, Orlando, FL., DeJesus E; Orlando Immunology Center, Orlando, FL.; University of Central Florida College of Medicine, Orlando, FL., Hinestrosa F; Orlando Immunology Center, Orlando, FL.; University of Central Florida College of Medicine, Orlando, FL.

المصدر: Medicine [Medicine (Baltimore)] 2021 Sep 24; Vol. 100 (38), pp. e27330.

نوع المنشور: Journal Article; Observational Study

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 2985248R Publication Model: Print Cited Medium: Internet ISSN: 1536-5964 (Electronic) Linking ISSN: 00257974 NLM ISO Abbreviation: Medicine (Baltimore) Subsets: MEDLINE

مواضيع طبية MeSH: Alanine/*therapeutic use , Emtricitabine/*therapeutic use , HIV Infections/*drug therapy , Piperazines/*therapeutic use , Pyridones/*therapeutic use , Tenofovir/*therapeutic use, Aged ; Aged, 80 and over ; Drug Combinations ; Drug Substitution ; Female ; Humans ; Male ; Middle Aged ; Retrospective Studies ; Treatment Outcome

المؤلفون: Rolle CP; Orlando Immunology Center, 1707 North Mills Avenue, Orlando, FL, 32803, USA. crolle@oicorlando.com.; Department of Global Health, Emory University Rollins School of Public Health, 1518 Clifton Road NE, Atlanta, GA, 30322, USA. crolle@oicorlando.com., Nguyen V; University of Central Florida College of Medicine, 6850 Lake Nona Blvd., Orlando, FL, 32827, USA., Hinestrosa F; Orlando Immunology Center, 1707 North Mills Avenue, Orlando, FL, 32803, USA.; University of Central Florida College of Medicine, 6850 Lake Nona Blvd., Orlando, FL, 32827, USA., DeJesus E; Orlando Immunology Center, 1707 North Mills Avenue, Orlando, FL, 32803, USA. edejesus@oicorlando.com.; University of Central Florida College of Medicine, 6850 Lake Nona Blvd., Orlando, FL, 32827, USA. edejesus@oicorlando.com.

المصدر: AIDS research and therapy [AIDS Res Ther] 2021 May 03; Vol. 18 (1), pp. 26. Date of Electronic Publication: 2021 May 03.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101237921 Publication Model: Electronic Cited Medium: Internet ISSN: 1742-6405 (Electronic) Linking ISSN: 17426405 NLM ISO Abbreviation: AIDS Res Ther Subsets: MEDLINE

مواضيع طبية MeSH: HIV Infections*/drug therapy , Nucleosides*, Heterocyclic Compounds, 3-Ring/therapeutic use ; Humans ; Oxazines ; Piperazines ; Pyridones ; Retrospective Studies ; Treatment Outcome ; Viral Load